rs10838267 - ALX4 - RPL7AP79

Magnitude 2.2 · 1 study on file

Reported associations

• Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses - Unknown journal (n.d.) · Unknown authors · PubMed 32424353

  ABSTRACT: Breast cancer susceptibility variants frequently show heterogeneity in associations by tumor subtype. To identify novel loci, we performed a genome-wide association study (GWAS) including 133,384 breast cancer cases and 113,789 controls, plus 18,908 BRCA1 mutation carriers (9,414 with breast cancer) of European ancestry, using both standard and novel methodologies that account for underlying tumor heterogeneity by estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status and tumor grade. We identified 32 novel susceptibility loci (P < 5.0 × 10−8), 15 of which showed evidence for associations with at least one tumor feature (false discovery rate (FDR) <0.05). Five loci showed associations (P<0.05) in opposite directions betwe

Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.